SNPs in ERCC1 and drug response to cisplatin in non-small-cell lung cancer patients

被引：0
|
作者：
Osawa, Kayo [1 ]
机构：
[1] Kobe Univ, Fac Hlth Sci, Grad Sch Hlth Sci, Suma Ku, Kobe, Hyogo 6540142, Japan
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 04期
关键词：
cisplatin; ERCC1; SNP; PLATINUM-BASED CHEMOTHERAPY; SINGLE NUCLEOTIDE POLYMORPHISMS; ADJUVANT CHEMOTHERAPY; EXCISION-REPAIR; DNA-REPAIR; XPD; ASSOCIATION;
D O I：
10.2217/PGS.11.15
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：445 / 447
页数：3
相关论文
共 50 条
  • [41] Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non-Small-Cell Lung Cancer Implications for Therapy
    Maus, Martin K. H.
    Mack, Philip C.
    Astrow, Stephanie H.
    Stephens, Craig L.
    Zeger, Gary D.
    Grimminger, Peter P.
    Hsiang, Jack H.
    Huang, Eric
    Li, Tianhong
    Lara, Primo N.
    Danenberg, Kathleen D.
    Gandara, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (05) : 582 - 586
  • [42] Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum
    Massuti, Bartomeu
    Cobo, Manuel
    Camps, Carlos
    Domine, Manuel
    Provencio, Mariano
    Alberola, Vicente
    Vinolas, Nuria
    Rosell, Rafael
    Taron, Miguel
    Gutierrez-Calderon, Vanesa
    Lardelli, Pilar
    Alfaro, Vicente
    Nieto, Antonio
    Isla, Dolores
    LUNG CANCER, 2012, 76 (03) : 354 - 361
  • [43] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    So-Yeon Park
    Yun-Chul Hong
    Jin-Hee Kim
    Seung-Min Kwak
    Jae-Hwa Cho
    Hong-Lyeol Lee
    Jeong-Seon Ryu
    Medical Oncology, 2006, 23 : 489 - 498
  • [44] Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?
    Rebecca S Heist
    Geoffrey Liu
    Wei Zhou
    Nature Clinical Practice Oncology, 2007, 4 : 564 - 565
  • [45] Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
    Suk, R
    Gurubhagavatula, S
    Park, S
    Zhou, W
    Su, L
    Lynch, TJ
    Wain, JC
    Neuberg, D
    Liu, G
    Christiani, DC
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1534 - 1538
  • [46] Cisplatin and gemcitabine in non-small-cell lung cancer
    Cartei, G
    Sacco, C
    Sibau, A
    Pella, N
    Iop, A
    Tabaro, G
    ANNALS OF ONCOLOGY, 1999, 10 : 57 - 62
  • [47] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Ryu, J
    Park, S
    Kwak, S
    Hong, Y
    Kim, J
    Cho, J
    Lee, H
    LUNG CANCER, 2005, 49 : S376 - S376
  • [48] Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?
    Heist, Rebecca S.
    Liu, Geoffrey
    Zhou, Wei
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (10): : 564 - 565
  • [49] SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer
    Nianli Liu
    Aoxing Chen
    Ning Feng
    Xiaochen Liu
    Longzhen Zhang
    Medical Oncology, 2021, 38
  • [50] SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer
    Liu, Nianli
    Chen, Aoxing
    Feng, Ning
    Liu, Xiaochen
    Zhang, Longzhen
    MEDICAL ONCOLOGY, 2021, 38 (05)
12345